Is cancer biology different in older patients?
Y Van Herck, A Feyaerts, S Alibhai… - The Lancet Healthy …, 2021 - thelancet.com
Roughly 50% of cancer cases occur in people aged 65 years or older. Older people are
often diagnosed at a later stage and might receive less (intensive) treatment, which might …
often diagnosed at a later stage and might receive less (intensive) treatment, which might …
Global and regional estimates of orphans attributed to maternal cancer mortality in 2020
Despite women being disproportionally affected by cancer deaths at young ages, there are
no global estimates of the resulting maternal orphans, who experience health and education …
no global estimates of the resulting maternal orphans, who experience health and education …
Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis
SM Hercules, M Alnajar, C Chen, SM Mladjenovic… - BMJ open, 2022 - bmjopen.bmj.com
Objective The aggressive triple-negative breast cancer (TNBC) subtype disproportionately
affects women of African ancestry across the diaspora, but its frequency across Africa has …
affects women of African ancestry across the diaspora, but its frequency across Africa has …
[HTML][HTML] Midkine as a driver of age-related changes and increase in mammary tumorigenesis
Aging is a pivotal risk factor for cancer, yet the underlying mechanisms remain poorly
defined. Here, we explore age-related changes in the rat mammary gland by single-cell …
defined. Here, we explore age-related changes in the rat mammary gland by single-cell …
Competitive endogenous role of the LINC00511/miR-185-3p axis and miR-301a-3p from liquid biopsy as molecular markers for breast cancer diagnosis
Breast cancer (BC) is the leading cause of female cancer-related mortalities. Evidence has
illustrated the role of long non-coding RNAs (lncRNA) and microRNAs (miRNA) as …
illustrated the role of long non-coding RNAs (lncRNA) and microRNAs (miRNA) as …
De novo and recurrent metastatic breast cancer–A systematic review of population-level changes in survival since 1995
SJ Lord, K Bahlmann, DL O'Connell, BE Kiely… - …, 2022 - thelancet.com
Background Advances in breast cancer (BC) care have reduced mortality, but their impact
on survival once diagnosed with metastasis is less well described. This systematic review …
on survival once diagnosed with metastasis is less well described. This systematic review …
Out-of-pocket payment and financial risk protection for breast cancer treatment: a prospective study from India
Background Available data on cost of cancer treatment, out-of-pocket payment and
reimbursement are limited in India. We estimated the treatment costs, out-of-pocket payment …
reimbursement are limited in India. We estimated the treatment costs, out-of-pocket payment …
[HTML][HTML] Correlation between age and hormone receptor status in women with breast cancer
A Shah, G Haider, N Abro, S Bhutto, TI Baqai, S Akhtar… - Cureus, 2022 - ncbi.nlm.nih.gov
Methods A cross-sectional study was conducted at the Department of Medical Oncology,
Jinnah Postgraduate Medical Center (JPMC), Karachi, Pakistan, from January 2021 to …
Jinnah Postgraduate Medical Center (JPMC), Karachi, Pakistan, from January 2021 to …
Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients
Background Breast cancer patients from the indigenous Arab population present much
earlier than patients from Western countries and have traditionally been underrepresented …
earlier than patients from Western countries and have traditionally been underrepresented …
Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results
NM Bruckmann, J Kirchner, J Morawitz, L Umutlu… - PLoS …, 2021 - journals.plos.org
Objectives To compare the diagnostic accuracy of contrast-enhanced thoraco-abdominal
computed tomography and whole-body 18F-FDG PET/MRI in N and M staging in newly …
computed tomography and whole-body 18F-FDG PET/MRI in N and M staging in newly …